| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 35 | 2021 | 434 | 4.020 |
Why?
|
| Cellular Senescence | 12 | 2022 | 94 | 3.620 |
Why?
|
| DNA Repair | 15 | 2022 | 356 | 3.470 |
Why?
|
| Saccharomyces cerevisiae Proteins | 24 | 2021 | 276 | 2.780 |
Why?
|
| DNA Damage | 22 | 2022 | 366 | 2.290 |
Why?
|
| Small Molecule Libraries | 6 | 2020 | 61 | 1.890 |
Why?
|
| Radiation Tolerance | 5 | 2022 | 168 | 1.720 |
Why?
|
| DNA Breaks, Double-Stranded | 8 | 2022 | 64 | 1.710 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2012 | 74 | 1.630 |
Why?
|
| Peptides | 13 | 2023 | 639 | 1.630 |
Why?
|
| Drug Repositioning | 4 | 2020 | 22 | 1.600 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 54 | 1.460 |
Why?
|
| Colonic Neoplasms | 3 | 2023 | 556 | 1.450 |
Why?
|
| Protein Kinase Inhibitors | 9 | 2019 | 589 | 1.280 |
Why?
|
| Fluorescent Dyes | 3 | 2022 | 242 | 1.270 |
Why?
|
| Cell Cycle Proteins | 15 | 2019 | 388 | 1.260 |
Why?
|
| Cell Cycle | 15 | 2013 | 502 | 1.230 |
Why?
|
| Lipids | 2 | 2020 | 269 | 1.200 |
Why?
|
| Protein Kinases | 6 | 2012 | 209 | 1.190 |
Why?
|
| Mitosis | 7 | 2019 | 153 | 1.150 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2021 | 579 | 1.120 |
Why?
|
| Phosphorylation | 24 | 2019 | 1106 | 1.080 |
Why?
|
| Flow Cytometry | 10 | 2023 | 679 | 1.060 |
Why?
|
| Radiation, Ionizing | 6 | 2019 | 121 | 1.050 |
Why?
|
| Cell Proliferation | 12 | 2020 | 1578 | 1.050 |
Why?
|
| Telomerase | 2 | 2022 | 55 | 1.040 |
Why?
|
| Microspheres | 3 | 2010 | 101 | 1.010 |
Why?
|
| Histones | 10 | 2019 | 311 | 1.000 |
Why?
|
| Neoplasms | 11 | 2021 | 2898 | 0.990 |
Why?
|
| MCF-7 Cells | 10 | 2022 | 106 | 0.980 |
Why?
|
| Proteomics | 5 | 2019 | 212 | 0.970 |
Why?
|
| Cancer Vaccines | 2 | 2023 | 156 | 0.900 |
Why?
|
| Lipofuscin | 1 | 2022 | 2 | 0.890 |
Why?
|
| Cyclins | 6 | 2018 | 82 | 0.880 |
Why?
|
| Mice | 27 | 2023 | 11352 | 0.880 |
Why?
|
| Animals | 47 | 2023 | 26582 | 0.860 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2022 | 11 | 0.850 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2020 | 23 | 0.840 |
Why?
|
| Fusion Proteins, bcr-abl | 4 | 2010 | 107 | 0.820 |
Why?
|
| Enzyme Assays | 2 | 2012 | 16 | 0.810 |
Why?
|
| Oxidative Stress | 4 | 2021 | 447 | 0.810 |
Why?
|
| Tumor Microenvironment | 5 | 2019 | 418 | 0.800 |
Why?
|
| Optical Imaging | 2 | 2021 | 48 | 0.790 |
Why?
|
| DNA Repair Enzymes | 2 | 2020 | 52 | 0.770 |
Why?
|
| X-Rays | 2 | 2017 | 130 | 0.770 |
Why?
|
| Magnetics | 2 | 2010 | 41 | 0.770 |
Why?
|
| CDC28 Protein Kinase, S cerevisiae | 5 | 2009 | 5 | 0.760 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 2360 | 0.760 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 479 | 0.750 |
Why?
|
| Fungal Proteins | 12 | 2018 | 141 | 0.750 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2021 | 113 | 0.740 |
Why?
|
| Dendritic Cells | 1 | 2023 | 425 | 0.740 |
Why?
|
| Receptor, ErbB-2 | 2 | 2018 | 223 | 0.730 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 532 | 0.730 |
Why?
|
| Photochemistry | 2 | 2012 | 38 | 0.730 |
Why?
|
| Camptothecin | 1 | 2020 | 189 | 0.720 |
Why?
|
| Nanomedicine | 2 | 2016 | 14 | 0.720 |
Why?
|
| B7-H1 Antigen | 2 | 2018 | 250 | 0.710 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2019 | 16 | 0.710 |
Why?
|
| Cytoprotection | 1 | 2019 | 47 | 0.700 |
Why?
|
| Carcinoma | 1 | 2023 | 436 | 0.690 |
Why?
|
| Glutamine | 2 | 2019 | 76 | 0.690 |
Why?
|
| Acylation | 1 | 2019 | 38 | 0.690 |
Why?
|
| Drug Discovery | 1 | 2020 | 103 | 0.680 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2018 | 14 | 0.680 |
Why?
|
| DNA | 8 | 2022 | 1294 | 0.670 |
Why?
|
| Biological Assay | 2 | 2010 | 78 | 0.670 |
Why?
|
| Quinolines | 1 | 2019 | 95 | 0.670 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2017 | 126 | 0.660 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 123 | 0.650 |
Why?
|
| Yeasts | 5 | 2008 | 49 | 0.650 |
Why?
|
| Homeodomain Proteins | 4 | 2022 | 536 | 0.630 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 2601 | 0.630 |
Why?
|
| G1 Phase | 6 | 2011 | 63 | 0.630 |
Why?
|
| Mice, Inbred BALB C | 6 | 2019 | 1047 | 0.610 |
Why?
|
| Genes, Fungal | 9 | 2009 | 58 | 0.610 |
Why?
|
| Humans | 68 | 2023 | 86643 | 0.610 |
Why?
|
| Glycolysis | 3 | 2015 | 129 | 0.590 |
Why?
|
| Adenosine Triphosphatases | 4 | 2014 | 153 | 0.580 |
Why?
|
| Aldehydes | 1 | 2016 | 17 | 0.580 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2019 | 43 | 0.580 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 301 | 0.570 |
Why?
|
| Software | 2 | 2012 | 654 | 0.560 |
Why?
|
| Cell Line, Tumor | 14 | 2020 | 2426 | 0.560 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 185 | 0.560 |
Why?
|
| K562 Cells | 9 | 2022 | 43 | 0.560 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2016 | 56 | 0.550 |
Why?
|
| Computational Biology | 1 | 2019 | 528 | 0.540 |
Why?
|
| Transcriptome | 2 | 2021 | 580 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-abl | 3 | 2015 | 30 | 0.530 |
Why?
|
| Oligonucleotides | 2 | 2013 | 92 | 0.530 |
Why?
|
| DNA, Fungal | 4 | 2018 | 57 | 0.520 |
Why?
|
| Plant Proteins | 3 | 2021 | 132 | 0.520 |
Why?
|
| Head and Neck Neoplasms | 2 | 2019 | 1052 | 0.510 |
Why?
|
| Hydrogels | 5 | 2010 | 82 | 0.510 |
Why?
|
| Exodeoxyribonucleases | 2 | 2018 | 14 | 0.510 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2020 | 78 | 0.510 |
Why?
|
| Cells, Cultured | 7 | 2023 | 2818 | 0.500 |
Why?
|
| Antibodies | 2 | 2013 | 350 | 0.490 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2019 | 371 | 0.490 |
Why?
|
| Gene Expression Regulation, Fungal | 8 | 2021 | 61 | 0.470 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2013 | 3 | 0.470 |
Why?
|
| RecQ Helicases | 1 | 2013 | 6 | 0.470 |
Why?
|
| Reproducibility of Results | 6 | 2022 | 2705 | 0.430 |
Why?
|
| Breast Neoplasms | 6 | 2019 | 2903 | 0.430 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 2262 | 0.420 |
Why?
|
| Candida albicans | 4 | 2018 | 32 | 0.420 |
Why?
|
| Proteome | 3 | 2012 | 124 | 0.410 |
Why?
|
| Mice, Nude | 7 | 2019 | 790 | 0.400 |
Why?
|
| Nanoparticles | 3 | 2018 | 157 | 0.400 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2016 | 458 | 0.400 |
Why?
|
| Immunohistochemistry | 4 | 2021 | 1753 | 0.400 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2016 | 46 | 0.390 |
Why?
|
| HEK293 Cells | 6 | 2021 | 615 | 0.390 |
Why?
|
| Photochemical Processes | 1 | 2010 | 14 | 0.390 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2010 | 302 | 0.380 |
Why?
|
| ErbB Receptors | 4 | 2018 | 485 | 0.380 |
Why?
|
| Luminescent Measurements | 1 | 2010 | 57 | 0.380 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2023 | 315 | 0.380 |
Why?
|
| Cell Fractionation | 1 | 2010 | 71 | 0.370 |
Why?
|
| Repressor Proteins | 3 | 2022 | 403 | 0.370 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 316 | 0.370 |
Why?
|
| Cell Polarity | 5 | 2002 | 115 | 0.370 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 297 | 0.370 |
Why?
|
| Immobilized Proteins | 1 | 2010 | 14 | 0.370 |
Why?
|
| Signal Transduction | 10 | 2010 | 3241 | 0.350 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2010 | 173 | 0.350 |
Why?
|
| Isotope Labeling | 1 | 2009 | 51 | 0.350 |
Why?
|
| Molecular Structure | 4 | 2020 | 287 | 0.350 |
Why?
|
| Databases, Protein | 1 | 2009 | 52 | 0.340 |
Why?
|
| Phosphopeptides | 2 | 2008 | 11 | 0.340 |
Why?
|
| Enzyme Inhibitors | 5 | 2020 | 639 | 0.340 |
Why?
|
| Lipid Peroxidation | 2 | 2020 | 44 | 0.340 |
Why?
|
| Antigen-Antibody Complex | 2 | 2021 | 87 | 0.340 |
Why?
|
| Amino Acid Sequence | 11 | 2020 | 2062 | 0.330 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2022 | 645 | 0.330 |
Why?
|
| Acetyltransferases | 5 | 2021 | 29 | 0.330 |
Why?
|
| Molecular Sequence Data | 12 | 2016 | 3030 | 0.330 |
Why?
|
| Models, Chemical | 3 | 2008 | 178 | 0.330 |
Why?
|
| Myosins | 6 | 1992 | 90 | 0.330 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2017 | 103 | 0.330 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2007 | 31 | 0.320 |
Why?
|
| Models, Biological | 8 | 2021 | 1749 | 0.310 |
Why?
|
| Phosphoproteins | 2 | 2008 | 254 | 0.310 |
Why?
|
| Nuclear Matrix-Associated Proteins | 2 | 2019 | 13 | 0.310 |
Why?
|
| Female | 21 | 2019 | 44532 | 0.310 |
Why?
|
| Chromatography, Liquid | 4 | 2017 | 104 | 0.300 |
Why?
|
| Genomic Instability | 2 | 2019 | 79 | 0.300 |
Why?
|
| Pyrimidines | 5 | 2010 | 370 | 0.300 |
Why?
|
| Proteins | 4 | 2009 | 777 | 0.300 |
Why?
|
| Radiotherapy | 2 | 2006 | 328 | 0.290 |
Why?
|
| Transcription Factors | 4 | 2022 | 1565 | 0.290 |
Why?
|
| Telomere | 2 | 2022 | 108 | 0.290 |
Why?
|
| Acetylation | 7 | 2021 | 121 | 0.290 |
Why?
|
| Membrane Proteins | 4 | 2018 | 1196 | 0.280 |
Why?
|
| Actins | 7 | 1994 | 451 | 0.280 |
Why?
|
| Checkpoint Kinase 2 | 6 | 2013 | 23 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2019 | 559 | 0.280 |
Why?
|
| Peptide Fragments | 4 | 2012 | 460 | 0.270 |
Why?
|
| Sepharose | 1 | 2005 | 14 | 0.270 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 178 | 0.270 |
Why?
|
| Genes, cdc | 2 | 2002 | 5 | 0.270 |
Why?
|
| Benzimidazoles | 3 | 2012 | 140 | 0.270 |
Why?
|
| Imatinib Mesylate | 4 | 2010 | 126 | 0.270 |
Why?
|
| Melanoma, Experimental | 2 | 2019 | 103 | 0.260 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 4 | 2022 | 72 | 0.260 |
Why?
|
| DNA-Binding Proteins | 5 | 2021 | 1208 | 0.260 |
Why?
|
| Hyphae | 3 | 2018 | 7 | 0.260 |
Why?
|
| Down-Regulation | 3 | 2019 | 504 | 0.260 |
Why?
|
| Histone Acetyltransferases | 4 | 2018 | 38 | 0.260 |
Why?
|
| Benzamides | 4 | 2010 | 229 | 0.250 |
Why?
|
| Cell Extracts | 3 | 2010 | 15 | 0.240 |
Why?
|
| Caspases | 1 | 2004 | 155 | 0.240 |
Why?
|
| Protein Binding | 11 | 2021 | 1456 | 0.240 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 3 | 2019 | 11 | 0.240 |
Why?
|
| Radiation-Sensitizing Agents | 2 | 2016 | 94 | 0.240 |
Why?
|
| Piperazines | 4 | 2010 | 272 | 0.240 |
Why?
|
| S Phase | 2 | 2005 | 62 | 0.240 |
Why?
|
| Pseudomonas syringae | 2 | 2021 | 47 | 0.230 |
Why?
|
| Plant Diseases | 2 | 2021 | 75 | 0.230 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 480 | 0.230 |
Why?
|
| Hyperoxaluria | 1 | 2023 | 26 | 0.230 |
Why?
|
| Spindle Apparatus | 1 | 2003 | 65 | 0.230 |
Why?
|
| Desmoglein 1 | 1 | 2022 | 7 | 0.230 |
Why?
|
| Chromogenic Compounds | 1 | 2022 | 5 | 0.220 |
Why?
|
| Galactosides | 1 | 2022 | 7 | 0.220 |
Why?
|
| Chromosomes, Fungal | 1 | 2002 | 15 | 0.220 |
Why?
|
| Cell Division | 5 | 2019 | 696 | 0.220 |
Why?
|
| beta-Galactosidase | 1 | 2022 | 71 | 0.220 |
Why?
|
| Antigens, Surface | 1 | 2022 | 101 | 0.220 |
Why?
|
| Glucose | 2 | 2019 | 638 | 0.220 |
Why?
|
| Epidermis | 1 | 2022 | 100 | 0.220 |
Why?
|
| Automation | 1 | 2002 | 106 | 0.220 |
Why?
|
| Microscopy | 1 | 2002 | 87 | 0.220 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 114 | 0.210 |
Why?
|
| Photomicrography | 1 | 2002 | 7 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 645 | 0.210 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2022 | 25 | 0.210 |
Why?
|
| Polyphosphates | 1 | 2021 | 7 | 0.210 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2021 | 13 | 0.210 |
Why?
|
| Bone Marrow | 1 | 2023 | 435 | 0.210 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 138 | 0.200 |
Why?
|
| Aldehyde-Lyases | 1 | 2021 | 15 | 0.200 |
Why?
|
| Chromosomes, Mammalian | 1 | 2021 | 36 | 0.200 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2021 | 29 | 0.200 |
Why?
|
| Genetic Therapy | 2 | 2017 | 342 | 0.200 |
Why?
|
| Cell Line | 5 | 2019 | 2468 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1999 | 222 | 0.200 |
Why?
|
| Haptens | 1 | 2021 | 9 | 0.200 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2021 | 90 | 0.200 |
Why?
|
| Tumor Burden | 3 | 2017 | 289 | 0.200 |
Why?
|
| Meiosis | 1 | 2001 | 80 | 0.200 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2021 | 18 | 0.200 |
Why?
|
| Tomography | 1 | 2021 | 20 | 0.200 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 268 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2021 | 1204 | 0.190 |
Why?
|
| Histocytochemistry | 1 | 2021 | 130 | 0.190 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 325 | 0.190 |
Why?
|
| Schizosaccharomyces pombe Proteins | 2 | 2007 | 35 | 0.190 |
Why?
|
| Apoptosis | 3 | 2020 | 1683 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2019 | 629 | 0.190 |
Why?
|
| Heat-Shock Response | 1 | 2021 | 47 | 0.190 |
Why?
|
| Calibration | 3 | 2010 | 99 | 0.190 |
Why?
|
| Molecular Chaperones | 3 | 2021 | 111 | 0.190 |
Why?
|
| Neuroendocrine Tumors | 1 | 2022 | 105 | 0.190 |
Why?
|
| Diterpenes | 1 | 2020 | 20 | 0.180 |
Why?
|
| Mass Spectrometry | 2 | 2012 | 188 | 0.180 |
Why?
|
| Quinazolines | 2 | 2012 | 220 | 0.180 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 13 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2022 | 292 | 0.180 |
Why?
|
| Kidney Calculi | 1 | 2023 | 339 | 0.180 |
Why?
|
| Pyrones | 1 | 2019 | 8 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 1999 | 41 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2021 | 100 | 0.180 |
Why?
|
| Aurora Kinase B | 1 | 2019 | 14 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2001 | 279 | 0.180 |
Why?
|
| Hexosamines | 1 | 2019 | 5 | 0.180 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 15 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2011 | 104 | 0.170 |
Why?
|
| Adenosine Triphosphate | 5 | 2011 | 314 | 0.170 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2019 | 13 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 10 | 0.170 |
Why?
|
| Antigens, Nuclear | 1 | 2019 | 25 | 0.170 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 52 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2019 | 74 | 0.170 |
Why?
|
| Cytoskeleton | 3 | 1995 | 193 | 0.170 |
Why?
|
| Cation Transport Proteins | 2 | 1999 | 64 | 0.170 |
Why?
|
| Morpholines | 1 | 2019 | 65 | 0.170 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 63 | 0.170 |
Why?
|
| Quinic Acid | 1 | 2018 | 1 | 0.170 |
Why?
|
| Image Cytometry | 1 | 2018 | 12 | 0.170 |
Why?
|
| Antibodies, Neoplasm | 1 | 2019 | 84 | 0.170 |
Why?
|
| Time Factors | 7 | 2016 | 5210 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 1 | 2021 | 252 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2005 | 279 | 0.170 |
Why?
|
| Cytokinesis | 1 | 2019 | 57 | 0.170 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1540 | 0.160 |
Why?
|
| Nocodazole | 3 | 2003 | 18 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 1961 | 0.160 |
Why?
|
| Cell Death | 1 | 2019 | 256 | 0.160 |
Why?
|
| DNA End-Joining Repair | 2 | 2019 | 3 | 0.160 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 350 | 0.160 |
Why?
|
| Polyethyleneimine | 1 | 2017 | 7 | 0.160 |
Why?
|
| Drug Carriers | 1 | 2018 | 81 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 1041 | 0.160 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 696 | 0.160 |
Why?
|
| Acyl Coenzyme A | 1 | 2017 | 17 | 0.160 |
Why?
|
| Male | 10 | 2021 | 40965 | 0.160 |
Why?
|
| Molecular Imaging | 1 | 2018 | 64 | 0.160 |
Why?
|
| Cell Movement | 2 | 2018 | 758 | 0.160 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 1686 | 0.160 |
Why?
|
| Collagen | 1 | 2019 | 269 | 0.150 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 138 | 0.150 |
Why?
|
| Models, Molecular | 5 | 2020 | 1286 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 152 | 0.150 |
Why?
|
| Plasmids | 1 | 2017 | 287 | 0.150 |
Why?
|
| Transcription, Genetic | 4 | 2022 | 1135 | 0.150 |
Why?
|
| Cytokines | 2 | 2019 | 776 | 0.150 |
Why?
|
| Morphogenesis | 4 | 2018 | 192 | 0.150 |
Why?
|
| Endothelial Cells | 2 | 2018 | 428 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2018 | 276 | 0.150 |
Why?
|
| Biomarkers, Tumor | 4 | 2021 | 1464 | 0.150 |
Why?
|
| Glutathione Transferase | 3 | 2005 | 111 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 5 | 2009 | 736 | 0.140 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2016 | 188 | 0.140 |
Why?
|
| Endocytosis | 1 | 2017 | 177 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 134 | 0.140 |
Why?
|
| Pancreas | 1 | 2018 | 239 | 0.140 |
Why?
|
| Cephalosporins | 1 | 2016 | 24 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 849 | 0.140 |
Why?
|
| Monocytes | 1 | 2017 | 214 | 0.140 |
Why?
|
| Genomics | 1 | 2022 | 720 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 269 | 0.140 |
Why?
|
| Biomarkers | 4 | 2021 | 1718 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 3092 | 0.140 |
Why?
|
| Cations, Monovalent | 1 | 1995 | 6 | 0.140 |
Why?
|
| Plant Immunity | 1 | 2015 | 13 | 0.140 |
Why?
|
| Acetylglucosamine | 1 | 2015 | 17 | 0.140 |
Why?
|
| Sodium Chloride | 1 | 1995 | 88 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 864 | 0.130 |
Why?
|
| Muscles | 3 | 1992 | 194 | 0.130 |
Why?
|
| Lamin Type A | 1 | 2015 | 24 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 4 | 2004 | 425 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2018 | 409 | 0.130 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2021 | 51 | 0.130 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 6 | 0.130 |
Why?
|
| Mutation | 10 | 2021 | 3968 | 0.130 |
Why?
|
| Muscular Diseases | 1 | 2015 | 63 | 0.130 |
Why?
|
| Up-Regulation | 1 | 2017 | 712 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 3 | 2011 | 49 | 0.130 |
Why?
|
| Algorithms | 1 | 2002 | 1830 | 0.120 |
Why?
|
| RNA Interference | 1 | 2015 | 369 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 544 | 0.120 |
Why?
|
| Macrophages | 1 | 2017 | 554 | 0.120 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 85 | 0.120 |
Why?
|
| Virulence Factors | 3 | 2021 | 108 | 0.120 |
Why?
|
| Replication Protein A | 1 | 2013 | 16 | 0.120 |
Why?
|
| Microbial Viability | 1 | 2013 | 31 | 0.120 |
Why?
|
| Cisplatin | 1 | 2016 | 612 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 408 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1384 | 0.120 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2012 | 5 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 246 | 0.110 |
Why?
|
| Magnetic Fields | 1 | 2012 | 11 | 0.110 |
Why?
|
| Cyclin D1 | 1 | 2012 | 83 | 0.110 |
Why?
|
| Antigens | 1 | 2013 | 228 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2010 | 64 | 0.110 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2016 | 383 | 0.110 |
Why?
|
| Peptide Mapping | 1 | 2012 | 26 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2012 | 1075 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2005 | 439 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 449 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 426 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 2002 | 273 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 592 | 0.100 |
Why?
|
| Culture Media | 3 | 2003 | 147 | 0.100 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 95 | 0.100 |
Why?
|
| Fluorenes | 1 | 2010 | 8 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 746 | 0.100 |
Why?
|
| Protein Transport | 2 | 2021 | 411 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2012 | 369 | 0.100 |
Why?
|
| Cell Adhesion | 2 | 2002 | 420 | 0.100 |
Why?
|
| Dasatinib | 1 | 2010 | 37 | 0.100 |
Why?
|
| Protein Array Analysis | 1 | 2010 | 50 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 286 | 0.090 |
Why?
|
| Neutrophils | 1 | 2012 | 307 | 0.090 |
Why?
|
| Immunoassay | 1 | 2010 | 92 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 189 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 621 | 0.090 |
Why?
|
| Cell-Free System | 1 | 2010 | 51 | 0.090 |
Why?
|
| Pyridones | 1 | 2010 | 51 | 0.090 |
Why?
|
| Cell Wall | 2 | 2018 | 66 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2022 | 105 | 0.090 |
Why?
|
| Thiazoles | 1 | 2010 | 131 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 428 | 0.090 |
Why?
|
| Acrylamides | 2 | 2006 | 30 | 0.090 |
Why?
|
| Muscle Contraction | 2 | 1987 | 283 | 0.080 |
Why?
|
| Phosphothreonine | 1 | 2008 | 3 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 120 | 0.080 |
Why?
|
| Sesquiterpenes | 1 | 2008 | 13 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 32 | 0.080 |
Why?
|
| Kinetics | 6 | 2003 | 1513 | 0.080 |
Why?
|
| Macrolides | 1 | 2008 | 31 | 0.080 |
Why?
|
| Stilbenes | 1 | 2007 | 25 | 0.080 |
Why?
|
| Pyridines | 1 | 2010 | 310 | 0.080 |
Why?
|
| Acrylic Resins | 2 | 2005 | 22 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6509 | 0.080 |
Why?
|
| Drug Design | 1 | 2008 | 124 | 0.080 |
Why?
|
| Cell Size | 2 | 1999 | 65 | 0.080 |
Why?
|
| Base Sequence | 4 | 2000 | 2330 | 0.070 |
Why?
|
| Actomyosin | 2 | 1987 | 46 | 0.070 |
Why?
|
| Mating Factor | 1 | 2006 | 4 | 0.070 |
Why?
|
| Homeostasis | 3 | 2018 | 409 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2006 | 2 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 674 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2007 | 345 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2006 | 65 | 0.070 |
Why?
|
| Chromatin | 2 | 2009 | 380 | 0.070 |
Why?
|
| HL-60 Cells | 2 | 2022 | 20 | 0.070 |
Why?
|
| Potassium | 2 | 1999 | 281 | 0.070 |
Why?
|
| RNA Stability | 1 | 2006 | 86 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2019 | 8489 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2007 | 1014 | 0.070 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2019 | 213 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 265 | 0.070 |
Why?
|
| Middle Aged | 3 | 2019 | 25028 | 0.070 |
Why?
|
| Carbon | 2 | 2002 | 80 | 0.070 |
Why?
|
| Mitochondria | 3 | 2011 | 535 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1197 | 0.060 |
Why?
|
| Magnesium | 1 | 2005 | 177 | 0.060 |
Why?
|
| Telomere-Binding Proteins | 1 | 2004 | 14 | 0.060 |
Why?
|
| Catalysis | 2 | 2020 | 203 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2008 | 814 | 0.060 |
Why?
|
| Temperature | 2 | 2002 | 396 | 0.060 |
Why?
|
| Aged | 2 | 2018 | 18415 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 391 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 683 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 416 | 0.060 |
Why?
|
| Biochemistry | 1 | 2004 | 27 | 0.060 |
Why?
|
| Education, Graduate | 1 | 2003 | 11 | 0.060 |
Why?
|
| Biological Science Disciplines | 1 | 2003 | 12 | 0.060 |
Why?
|
| Kinetochores | 1 | 2003 | 7 | 0.060 |
Why?
|
| Oxalobacter formigenes | 1 | 2023 | 5 | 0.060 |
Why?
|
| Subcellular Fractions | 2 | 2021 | 93 | 0.060 |
Why?
|
| Science | 1 | 2003 | 34 | 0.060 |
Why?
|
| Vacuoles | 1 | 2003 | 46 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2023 | 123 | 0.060 |
Why?
|
| Oxalates | 1 | 2023 | 48 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2010 | 69 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 557 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 36 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2002 | 34 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2005 | 881 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2002 | 49 | 0.060 |
Why?
|
| Hexoses | 1 | 2002 | 4 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2002 | 55 | 0.050 |
Why?
|
| Raffinose | 1 | 2002 | 24 | 0.050 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2002 | 8 | 0.050 |
Why?
|
| Ethanol | 2 | 2002 | 249 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 122 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 488 | 0.050 |
Why?
|
| Endosomes | 1 | 2022 | 75 | 0.050 |
Why?
|
| Second Messenger Systems | 1 | 2002 | 41 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2021 | 579 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2012 | 692 | 0.050 |
Why?
|
| Glycerol | 1 | 2002 | 32 | 0.050 |
Why?
|
| Gamma Rays | 1 | 2002 | 72 | 0.050 |
Why?
|
| Polymers | 2 | 2018 | 202 | 0.050 |
Why?
|
| U937 Cells | 1 | 2022 | 32 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 46 | 0.050 |
Why?
|
| Microtubules | 1 | 2002 | 119 | 0.050 |
Why?
|
| Serum | 2 | 2017 | 25 | 0.050 |
Why?
|
| DNA Replication | 1 | 2002 | 164 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2022 | 45 | 0.050 |
Why?
|
| Cyclin B | 1 | 2001 | 17 | 0.050 |
Why?
|
| Cadherins | 1 | 2022 | 151 | 0.050 |
Why?
|
| Keratinocytes | 1 | 2022 | 143 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 379 | 0.050 |
Why?
|
| Cattle | 2 | 2017 | 376 | 0.050 |
Why?
|
| Zinc | 1 | 2021 | 91 | 0.050 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2012 | 90 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 192 | 0.050 |
Why?
|
| Proteostasis | 1 | 2021 | 8 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2021 | 23 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2007 | 782 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 270 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2021 | 347 | 0.050 |
Why?
|
| Haploidy | 2 | 1997 | 31 | 0.050 |
Why?
|
| Virulence | 1 | 2021 | 271 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 373 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2022 | 280 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2022 | 105 | 0.050 |
Why?
|
| Cytosol | 1 | 2021 | 189 | 0.050 |
Why?
|
| Workflow | 1 | 2021 | 77 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2021 | 165 | 0.050 |
Why?
|
| Rabbits | 3 | 1992 | 636 | 0.050 |
Why?
|
| Cycloaddition Reaction | 1 | 2020 | 6 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 111 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2021 | 258 | 0.050 |
Why?
|
| Adult | 2 | 2018 | 25648 | 0.050 |
Why?
|
| Actin Cytoskeleton | 3 | 1991 | 192 | 0.050 |
Why?
|
| Rats | 2 | 2021 | 3990 | 0.040 |
Why?
|
| G2 Phase | 1 | 1999 | 34 | 0.040 |
Why?
|
| Binding Sites | 2 | 2015 | 1098 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2021 | 179 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 1721 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 927 | 0.040 |
Why?
|
| Mammals | 1 | 2021 | 227 | 0.040 |
Why?
|
| Biological Transport | 3 | 2011 | 396 | 0.040 |
Why?
|
| Salts | 1 | 1999 | 16 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 250 | 0.040 |
Why?
|
| Movement | 2 | 1992 | 299 | 0.040 |
Why?
|
| Prognosis | 2 | 2017 | 3679 | 0.040 |
Why?
|
| Selectins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2019 | 22 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2018 | 19 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 309 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2019 | 244 | 0.040 |
Why?
|
| Endodeoxyribonucleases | 1 | 2018 | 11 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2023 | 669 | 0.040 |
Why?
|
| Myosin Subfragments | 4 | 1991 | 6 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1219 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 63 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 128 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 646 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2019 | 249 | 0.040 |
Why?
|
| Arterioles | 1 | 2018 | 22 | 0.040 |
Why?
|
| Somatostatin | 1 | 2018 | 55 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2018 | 44 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 136 | 0.040 |
Why?
|
| Reproduction | 1 | 1999 | 195 | 0.040 |
Why?
|
| Flocculation | 1 | 1997 | 1 | 0.040 |
Why?
|
| Alleles | 1 | 2001 | 1128 | 0.040 |
Why?
|
| Diploidy | 1 | 1997 | 30 | 0.040 |
Why?
|
| Glucagon | 1 | 2018 | 111 | 0.040 |
Why?
|
| Frozen Sections | 1 | 2018 | 48 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 498 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 39 | 0.040 |
Why?
|
| Capillaries | 1 | 2018 | 91 | 0.040 |
Why?
|
| Biofilms | 1 | 2017 | 42 | 0.040 |
Why?
|
| Tic Disorders | 1 | 1997 | 8 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 937 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 339 | 0.040 |
Why?
|
| Genes, Switch | 1 | 1996 | 8 | 0.040 |
Why?
|
| cdc25 Phosphatases | 1 | 2016 | 18 | 0.040 |
Why?
|
| Nickel | 1 | 1996 | 13 | 0.040 |
Why?
|
| Point Mutation | 1 | 1997 | 246 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 85 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 503 | 0.040 |
Why?
|
| Nucleic Acids | 1 | 1996 | 30 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2016 | 252 | 0.030 |
Why?
|
| Cell Survival | 2 | 2012 | 969 | 0.030 |
Why?
|
| Calcineurin | 1 | 1995 | 16 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1995 | 20 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1995 | 72 | 0.030 |
Why?
|
| Lithium | 1 | 1995 | 59 | 0.030 |
Why?
|
| Glass | 2 | 2004 | 15 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 57 | 0.030 |
Why?
|
| Genotype | 1 | 2000 | 1851 | 0.030 |
Why?
|
| Ion Transport | 1 | 1995 | 81 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1999 | 673 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 100 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1996 | 179 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 44 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1995 | 78 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 134 | 0.030 |
Why?
|
| Amino Acids | 1 | 2015 | 252 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1995 | 281 | 0.030 |
Why?
|
| Videotape Recording | 1 | 1994 | 47 | 0.030 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1997 | 157 | 0.030 |
Why?
|
| Tubulin | 1 | 1994 | 58 | 0.030 |
Why?
|
| Sodium | 1 | 1995 | 341 | 0.030 |
Why?
|
| Schizosaccharomyces | 1 | 1994 | 54 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1538 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1458 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2013 | 45 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 1160 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1992 | 34 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1992 | 28 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 35 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1992 | 81 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2232 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1992 | 332 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 853 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1376 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2011 | 5 | 0.030 |
Why?
|
| Antimycin A | 1 | 2011 | 13 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 38 | 0.020 |
Why?
|
| Buffers | 1 | 1991 | 26 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 72 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2011 | 90 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2010 | 17 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 83 | 0.020 |
Why?
|
| Phenotype | 2 | 2012 | 2378 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 303 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 90 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 458 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 8 | 0.020 |
Why?
|
| Video Recording | 1 | 1991 | 190 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2009 | 39 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 55 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 116 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 305 | 0.020 |
Why?
|
| Light | 2 | 2006 | 289 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 406 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 728 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 351 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 207 | 0.020 |
Why?
|
| Electron Transport Complex III | 1 | 2008 | 12 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2008 | 14 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1987 | 989 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4213 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2007 | 54 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 1863 | 0.020 |
Why?
|
| Sirtuins | 1 | 2007 | 45 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Etoposide | 1 | 2007 | 196 | 0.020 |
Why?
|
| Phalloidine | 1 | 1986 | 9 | 0.020 |
Why?
|
| Rhodamines | 1 | 1986 | 18 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 376 | 0.020 |
Why?
|
| Dictyostelium | 1 | 1986 | 43 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 691 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 7993 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2005 | 14 | 0.020 |
Why?
|
| Cobalt | 1 | 2005 | 29 | 0.020 |
Why?
|
| Adsorption | 1 | 2005 | 54 | 0.020 |
Why?
|
| Polylysine | 1 | 2005 | 33 | 0.020 |
Why?
|
| Biotinylation | 1 | 2005 | 41 | 0.020 |
Why?
|
| Biopolymers | 1 | 2005 | 26 | 0.020 |
Why?
|
| Manganese | 1 | 2005 | 53 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1986 | 493 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 133 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 302 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 381 | 0.020 |
Why?
|
| Epitopes | 1 | 2005 | 255 | 0.020 |
Why?
|
| Lysine | 1 | 2005 | 147 | 0.020 |
Why?
|
| Methylation | 1 | 2005 | 251 | 0.020 |
Why?
|
| Enzymes, Immobilized | 1 | 2004 | 11 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2005 | 154 | 0.020 |
Why?
|
| Serine | 1 | 2004 | 99 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2005 | 329 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 193 | 0.010 |
Why?
|
| Natural Science Disciplines | 1 | 2003 | 3 | 0.010 |
Why?
|
| Formaldehyde | 1 | 2004 | 52 | 0.010 |
Why?
|
| Training Support | 1 | 2003 | 23 | 0.010 |
Why?
|
| Hydrolysis | 2 | 1996 | 141 | 0.010 |
Why?
|
| Faculty | 1 | 2003 | 30 | 0.010 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 15 | 0.010 |
Why?
|
| Mathematics | 1 | 2003 | 190 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2003 | 80 | 0.010 |
Why?
|
| Nitrogen | 1 | 2003 | 70 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 2003 | 239 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 2002 | 36 | 0.010 |
Why?
|
| Fermentation | 1 | 2002 | 13 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2002 | 52 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 674 | 0.010 |
Why?
|
| Mentors | 1 | 2003 | 76 | 0.010 |
Why?
|
| Universities | 1 | 2003 | 135 | 0.010 |
Why?
|
| Benzoquinones | 1 | 2002 | 27 | 0.010 |
Why?
|
| Biotechnology | 1 | 2002 | 28 | 0.010 |
Why?
|
| Peptide Library | 1 | 2002 | 84 | 0.010 |
Why?
|
| Aorta | 1 | 2003 | 280 | 0.010 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2000 | 3 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 47 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 41 | 0.010 |
Why?
|
| Porins | 1 | 2000 | 21 | 0.010 |
Why?
|
| Electron Transport | 1 | 2000 | 71 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 117 | 0.010 |
Why?
|
| Methylamines | 1 | 1999 | 5 | 0.010 |
Why?
|
| Cations | 1 | 1999 | 30 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 726 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2000 | 239 | 0.010 |
Why?
|
| Curriculum | 1 | 2003 | 539 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1999 | 435 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1997 | 66 | 0.010 |
Why?
|
| Tourette Syndrome | 1 | 1997 | 25 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 108 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 68 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 39 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1996 | 69 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 1996 | 42 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2000 | 502 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1996 | 332 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1997 | 487 | 0.010 |
Why?
|
| Sex Factors | 1 | 1997 | 1054 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 1074 | 0.010 |
Why?
|
| Comorbidity | 1 | 1997 | 943 | 0.010 |
Why?
|
| Age Factors | 1 | 1997 | 1851 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1996 | 926 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 1981 | 0.010 |
Why?
|
| Subtilisins | 1 | 1990 | 27 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1990 | 114 | 0.010 |
Why?
|
| Collodion | 1 | 1987 | 7 | 0.000 |
Why?
|
| Adolescent | 1 | 1997 | 8981 | 0.000 |
Why?
|